China Health Technology Clarifies Executive’s English Name in Corporate Filings

Bulletin Express05-29

On 29 May 2026, China Health Technology Group Holding Company Limited released a clarification correcting the English name of its chairman, executive director and chief executive officer. The Board disclosed that the name of Ms. Bi Xue was previously misstated as “Bu Xue” across announcements, circulars, and reports issued since 14 August 2023.

The Company confirmed that Ms. Bi’s Chinese name (畢雪) has always been accurate and that only the English transliteration required amendment. All historical references to “Bu Xue” should be read as “Bi Xue.” No other details in the affected documents have been altered.

Appointment timeline for Ms. Bi: • 14 August 2023 – Joined the Board as an independent non-executive director • 1 April 2025 – Re-designated as an executive director • 1 December 2025 – Appointed chief executive officer • 31 December 2025 – Elevated to chairman of the Board

The current Board comprises: • Executive Directors: Ms. Bi Xue (Chairman and CEO), Ms. Wong Hoi Ying • Independent Non-Executive Directors: Mr. Chau Wing Nam, Ms. Liu Shuhua, Mr. Li Liangjie

The Board issued an apology for any confusion caused by the typographical error.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment